SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-000461
Filing Date
2021-01-12
Accepted
2021-01-12 06:03:51
Documents
6
Period of Report
2021-01-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_011121.htm 8-K 45408
2 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 16674
3 PLACEMENT AGENCY AGREEMENT ex10-01.htm EX-10.01 67774
4 FORM OF SECURITIES PURCHASE AGREEMENT ex10-02.htm EX-10.02 206924
5 PRESS RELEASE ex99-01.htm EX-99.01 15283
6 GRAPHIC ex5-01_img001.jpg GRAPHIC 14440
  Complete submission text file 0001387131-21-000461.txt   373323
Mailing Address 28 MAIN STREET CHATHAM NJ 07928
Business Address 28 MAIN STREET CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 21522335
SIC: 2834 Pharmaceutical Preparations